Plasma bradykinin in angio-oedema

Lancet

Volumn 351, Issue 9117, 1998, Pages 1693-1697

  Nussberger, Juerg ^b   Cugno, Massimo ^a   Amstutz, Catherine ^c   Cicardi, Marco ^a   Pellacani, Andrea ^c   Agostoni, Angelo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CAPTOPRIL; COMPLEMENT COMPONENT C1S INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0032490360     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09137-X     Document Type: Article

References (23)

1. 1 Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am J Med 1963; 31: 37-44.
2. 2 Caldwell JR, Ruddy S, Schur PH, Austen KF. Acquired C1-inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol 1972; 1: 39-52.
3. 3 Cicardi M, Beretta A, Colombo M, Gioffré D, Cugno M, Agostoni A. Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema. Clin Exp Immunol 1996; 106: 475-80.
4. 4 Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldson VH. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 1971; 50: 2143-49.
5. 5 Jackson J, Sim RB, Whelan A, Feighery C. An IgG auto antibody which inactivates C1-inhibitor. Nature 1986; 323: 722-24.
6. 6 Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976; 84: 580-93.
7. 7 Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine 1992; 71: 206-15.
8. 8 Fields T, Ghebrehiwet B, Kaplan AP. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol 1983; 72: 54-60.
9. 9 Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III. Hereditary angioneurotic oedema: characterisation of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 1994; 95: 22-28.
10. 10 Donaldson VH, Rosen FS, Bing DH. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema plasma. Trans Am Assoc Phys 1977; 90: 174-87.
11. 11 Dela Cadena RA, Wachtfogel YT, Colman RW. Contact activation pathway: inflammation and coagulation. In: Colman RW, Hirsh J, Marder WJ, Salzman EW, eds. Hemostasis and thrombosis: principles and clinical practice. Philadelphia: Lippincott, 1994: 219-40.
12. 12 Davies AE III. C1-inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988; 6: 595-628.
13. 13 Donaldson VH. The challenge of hereditary angioneurotic edema. N Engl J Med 1983; 308: 1094-95.
14. 14 Cugno M, Cicardi M, Bottasso B, et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997; 89: 3213-18.
15. 15 Curd JG, Prograis LJ Jr, Cochrane CG. Detection of active kallikreine in induced blister fluids of hereditary angioedema patients. J Exp Med 1980; 152: 742-47.
16. 16 Shapira M, Silver LD, Scott CF, et al. Prekallikreine activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med 1983; 308: 1050-54.
17. 443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol 1997; 159: 983-88.
18. 18 Lung CC, Chan EKL, Zuraw BL. Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1-inhibitor deficiency. J Allergy Clin Immunol 1997; 99: 134-46.
19. 19 Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234-42.
20. 20 Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci 1994; 87: 567-74.
21. 21 Talamo RC, Haber E, Austen KF. A radioimmunoassay for bradykinin in plasma and synovial fluid. J Lab Clin Med 1969; 74: 816-27.
22. 22 Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988; 260: 967-70.
23. 23 Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikrein, kininogens and kininases. Pharmacol Rev 1992; 44: 1-80.